You are currently viewing archive.bio.org. Head to our home page to check out our fresh new look!

BIO Submits Comments to CMS Regarding the CY 2011 Physician Fee Schedule Proposed Rule

<p>
The Biotechnology Industry Organization (BIO) appreciates the opportunity to comment on the Centers for Medicare &amp; Medicaid Services&#39; (CMS) proposed rule regarding payment policies under the physician fee schedule (PFS) and other revisions to Part B for calendar year (CY) 2011 (the &quot;Proposed Rule&quot;).</p>

The Biotechnology Industry Organization (BIO) appreciates the opportunity to comment on the Centers for Medicare & Medicaid Services' (CMS) proposed rule regarding the payment policies under the physician fee schedule (PFS) and other revisions to Part B for calendar year (CY) 2011 (the "Proposed Rule"). BIO represents more than 1,200 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial, and environmental biotechnology products.

See the full comment letter here.